Inventor · disambiguated record
Alexander M. Taylor
Also filed as: TAYLOR ALEXANDER M
27 granted patents·12 pending applications·186 citations·filing 2011–2023
95Inventor score
Files withRELAY THERAPEUTICS INC18GENENTECH INC15ALBRECHT BRIAN K4CONSTELLATION PHARMACEUTICALS INC2
Top patents by PatentIndex Score
39 records- 0197US9249161B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2011·Granted Feb 2, 2016·50 cites·12 claims
- 0296US10934302B1SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·44 cites·7 claims
- 0392US9763922B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2015·Granted Sep 19, 2017·9 cites·20 claims
- 0492US8796261B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2011·Granted Aug 5, 2014·21 cites·28 claims
- 0591US12084447B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Sep 10, 2024·2 cites·20 claims
- 0690US9624244B2Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2013·Granted Apr 18, 2017·8 cites·6 claims
- 0790US9328117B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2012·Granted May 3, 2016·8 cites·15 claims
- 0887US10308614B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jun 4, 2019·4 cites·21 claims
- 0987US9522920B2Bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Dec 20, 2016·10 cites·21 claims
- 1086US11701354B2Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Jul 18, 2023·3 cites·40 claims
- 1186US9422292B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2012·Granted Aug 23, 2016·5 cites·17 claims
- 1285US11591336B2Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Feb 28, 2023·3 cites·54 claims
- 1384US11529347B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Dec 20, 2022·4 cites·8 claims
- 1483US10206931B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 19, 2019·5 cites·17 claims
- 1582US11890281B2SHP2 phosphatase inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2020·Granted Feb 6, 2024·1 cites·27 claims
- 1681US11629145B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Apr 18, 2023·3 cites·18 claims
- 1779US10183009B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jan 22, 2019·3 cites·22 claims
- 1878US12331056B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Granted Jun 17, 2025·0 cites·21 claims
- 1978US10239861B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Mar 26, 2019·2 cites·7 claims
- 2071US2024122925A1Shp2 phosphatase inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2168US10150767B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Dec 11, 2018·1 cites·14 claims
- 2265US2022315586A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2359US2024368122A1Jak2 inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2458US2025388565A1Estrogen receptor alpha degraders and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2557US2024190855A1Cdk inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2656US2025090540A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2755US2017333406A1Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2854US2025084048A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2954US2025019380A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3049US2020392161A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3147US10358437B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jul 23, 2019·0 cites·9 claims
- 3241US10301253B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted May 28, 2019·0 cites·21 claims
- 3341US2016024504A1Treating th2-mediated diseases by inhibition of bromodomainsGENENTECH INC·Filed 2014·Application pending·0 cites
- 3440US12138263B2Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Granted Nov 12, 2024·0 cites·16 claims
- 3540US10280149B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted May 7, 2019·0 cites·21 claims
- 3640US10258603B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Apr 16, 2019·0 cites·15 claims
- 3740US10202354B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 12, 2019·0 cites·16 claims
- 3838US10155764B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Dec 18, 2018·0 cites·23 claims
- 3936US2016317632A1Use of cbp/ep300 bromodomain inhibitors for cancer immunotherapyGENENTECH INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexander M. Taylor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →